September 3, 2009 / 7:26 AM / 10 years ago

India's Ranbaxy to launch generic Rocaltrol in U.S.

BANGALORE, Sept 3 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd RANB.BO said on Thursday it would launch in the United States a generic version of Rocaltrol used in the treatment of ailments arising from renal failure. Ranbaxy will market the drug, which has annual sales worth $70 million, in an agreement with Validus Pharmaceuticals, a U.S.-based company focused on acquiring and marketing prescription drugs.

Ranbaxy, in which Japan’s Daiichi Sankyo (4568.T) bought about 64 percent last year, said in a statement it would launch the drug immediately and expected to be the only firm offering the generic version of Rocaltrol. (Reporting by Sumeet Chatterjee)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below